Infigratinib(Truseltiq)

Another NameLuciNfig,Truseltiq,英菲格拉替尼,英飞替尼

IndicationsIt is indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 gene abnormalities.